WCO classification path
- Chapter30Pharmaceutical products
- Heading3004Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (iincluding those in the form of transdermal administration systems) or in forms or packings for retail sale
- Subheading300490Other
- National30049096- - - Nasal-drop medicaments containing naphazoline, xylometazoline or oxymetazoline
30049096
"- - - Nasal-drop medicaments containing naphazoline, xylometazoline or oxymetazoline"
HS code 30049096 (Chapter 30 "Pharmaceutical products"; Heading 3004 "Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (iincluding those in the form of transdermal administration systems) or in forms or packings for retail sale"; Subheading 300490 "Other") under the Indonesia tariff schedule classifies "- - - Nasal-drop medicaments containing naphazoline, xylometazoline or oxymetazoline". Indonesia customs apply Import duty (MFN) of 5.00, VAT (PPN) 12.00. This commodity is subject to 7 import regulations or restrictions; see compliance section below. 19 free trade agreement preferential rates are available for this code.
Tariff Schedule
| Classification | Rate |
|---|---|
MFN 进口税 Import duty (MFN) | 5.00 |
增值税 (PPN) VAT (PPN) | 12.00 |
FTA Preferential Rates
19 agreements available · certificate of origin required
| Agreement | Rate |
|---|---|
| AANZFTA (ASEAN Australia New Zealand Free Trade Agreement) | 0% |
| ACFTA (ASEAN - China Free Trade Area) | 0% |
| AJCEP (ASEAN-Japan Comprehensive Economic Partnership) | 0% |
| AKFTA (ASEAN Korea Free Trade Agreement) | 0% |
| ATIGA (ASEAN Trade in Goods Agreement) | 0% |
| IACEPA (Indonesia-Australia Comprehensive Economic Partnership Agreement) | 0% |
| ICCEPA (Indonesia-Chile Comprehensive Economic Partnership Agreement) | 0% |
| IECEPA (Indonesia-European Free Trade Association Comprehensive Economic Parthership) | 0% |
| IJEPA (Indonesia - Japan Economic Partnership Agreement) | 0% |
| IKCEPA (Indonesia-Korea Comprehensive Partnership Agreement) | 0% |
| RCEP-ASEAN (Regional Comprehensive Economic Partnership Agreement - ASEAN) | 0% |
| RCEP-Australia (Regional Comprehensive Economic Partnership Agreement - Australia) | 0% |
| RCEP-China (Regional Comprehensive Economic Partnership Agreement - China) | 0% |
| RCEP-Japan (Regional Comprehensive Economic Partnership Agreement - Japan) | 0% |
| RCEP-Korea (Regional Comprehensive Economic Partnership Agreement - Korea) | 0% |
| RCEP-New Zealand (Regional Comprehensive Economic Partnership Agreement - New Zealand) | 0% |
| AHKFTA (ASEAN-Hong Kong Free Trade Agreement) | 5% |
| AIFTA (ASEAN India Free Trade Agreement) | 4% |
| IUAE-CEPA (Indonesia–United Arab Emirates Comprehensive Economic Partnership Agreement) | 1% |
Compliance & Controls
7 import regulations, restrictions, or permit requirements
Surat Keterangan Impor / Special Access Scheme (SAS)
- - - Obat tetes hidung mengandung naphazoline, xylometazoline atau oxymetazoline
Surat Keterangan Impor / Special Access Scheme (SAS)
- - - Obat tetes hidung mengandung naphazoline, xylometazoline atau oxymetazoline
Surat Keterangan Impor / Special Access Scheme (SAS)
- - - Obat tetes hidung mengandung naphazoline, xylometazoline atau oxymetazoline
Surat Keterangan Impor / Special Access Scheme (SAS)
- - - Obat tetes hidung mengandung naphazoline, xylometazoline atau oxymetazoline
Surat Keterangan Impor / Special Access Scheme (SAS)
- - - Obat tetes hidung mengandung naphazoline, xylometazoline atau oxymetazoline
Surat Keterangan Impor / Special Access Scheme (SAS)
- - - Obat tetes hidung mengandung naphazoline, xylometazoline atau oxymetazoline
Surat Keterangan Impor / Special Access Scheme (SAS)
- - - Obat tetes hidung mengandung naphazoline, xylometazoline atau oxymetazoline
Global Benchmark
HS-6 prefix 3004.90 across other jurisdictions